Merial, Ltd., a prominent player in the animal health industry, operates its St. Louis Blending Facility in the United States, focusing on the development and production of anticoccidial products. Founded in the early 1990s, Merial has established itself as a leader in veterinary pharmaceuticals, particularly in the prevention and treatment of coccidiosis in livestock and poultry. With a commitment to innovation, Merial's core offerings include a range of anticoccidial solutions that are distinguished by their efficacy and safety profiles. The company has achieved significant milestones, including numerous regulatory approvals and partnerships that enhance its market position. Renowned for its dedication to animal welfare and sustainable practices, Merial continues to set industry standards, making it a trusted name among veterinarians and livestock producers alike.
We don't have data for Merial, Ltd., St. Louis Blending Facility and Anticoccidial Products Rights, but we can show you information about their parent organization instead.
View parent company